A3 Adenosine Receptors and Lung Injury After Reperfusion
Author Information
Author(s): Idit Matot, Carolyn F Weiniger, Evelyne Zeira, Eithan Galun, Bhalchandra V Joshi, Kenneth A Jacobson
Primary Institution: Hadassah University Medical Center, The Hebrew University, Jerusalem, Israel
Hypothesis
Does A3 adenosine receptor stimulation with reperfusion modulate expression of different mitogen-activated protein kinases?
Conclusion
A3 adenosine receptor activation protects against lung injury and apoptosis during reperfusion by upregulating phosphorylated ERK.
Supporting Evidence
- Both A3 adenosine receptor agonists significantly reduced lung injury and apoptosis.
- MRS3558 was found to be more potent than IB-MECA in reducing lung injury.
- Phosphorylated ERK1/2 levels increased after reperfusion, indicating activation of protective pathways.
Takeaway
This study found that a special receptor in the lungs can help protect them from damage when blood flow is restored after being stopped for a while.
Methodology
In vivo studies were performed on cats where the left lower lobe of the lung was isolated and subjected to ischemia and reperfusion, with administration of A3 adenosine receptor agonists.
Limitations
The study was conducted in an isolated lung model, which may not fully represent in vivo conditions.
Participant Demographics
Adult cats weighing 2.5 to 3.5 kg.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website